Literature DB >> 20299178

Quality of life before surgery is a predictive factor for satisfaction among patients undergoing sympathectomy to treat hyperhidrosis.

Nelson Wolosker1, Guilherme Yazbek, José Ribas Milanez de Campos, Marco Antonio Munia, Paulo Kauffman, Fábio Biscegli Jatene, Pedro Puech-Leao.   

Abstract

PURPOSE: The objective of this study was to evaluate the postoperative quality of life (QOL) experienced among a group of 1167 patients who underwent video-assisted thoracoscopic sympathectomy (VATS) to treat primary hyperhidrosis, as compared with the presurgical QOL.
METHODS: Between February 2002 and June 2007, 1167 patients who had undergone VATS were surveyed. The majority had presented with palmar hyperhidrosis (794 patients; 68%), while 340 (29%) had presented with axillary hyperhidrosis. Based on data obtained from the QOL protocol applied to all of the patients preoperatively, the patients were divided into two groups according to the level of their QOL: group 1 consisted of 312 patients (27%) with poor QOL and group 2 of 855 patients (73%) with very poor QOL. The same protocol was applied postoperatively, and five different levels of satisfaction were obtained. The same parameters were evaluated for both the palmar and the axillary hyperhidrosis subgroups.
RESULTS: The patients with very poor QOL had much better results in terms of improvement in QOL than did those with poor QOL (P < .05). The same result was observed for both the palmar and axillary hyperhidrosis subgroups (P < .05).
CONCLUSION: The worse the preoperative QOL among patients undergoing sympathectomy to treat primary hyperhidrosis is, the better the postoperative improvement in QOL will be. Copyright (c) 2010 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20299178     DOI: 10.1016/j.jvs.2009.11.078

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  7 in total

1.  Infraareolar access for thoracoscopic sympathectomy to treat primary hyperhidrosis.

Authors:  Sônia Oliveira Lima; Yasmin Gama Abuawad; Paulo Sérgio Faro Santos; Aloisio Ferreira Pinto Neto; Vanessa Rocha de Santana; Francisco Prado Reis
Journal:  Surg Today       Date:  2012-06-06       Impact factor: 2.549

Review 2.  Thoracic sympathectomy: a review of current indications.

Authors:  Moshe Hashmonai; Alan E P Cameron; Peter B Licht; Chris Hensman; Christoph H Schick
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

3.  Quality of life after endoscopic lumbar sympathectomy for primary plantar hyperhidrosis.

Authors:  Roman Rieger; Sonja Pedevilla; Johannes Lausecker
Journal:  World J Surg       Date:  2015-04       Impact factor: 3.352

4.  Semi-Fowler vs. lateral decubitus position for thoracoscopic sympathectomy in treatment of primary focal hyperhidrosis.

Authors:  Ivan Kuhajda; Dejan Djuric; Koledin Milos; Milorad Bijelovic; Misel Milosevic; Dejan Ilincic; Miroslav Ilic; Bojan Koledin; Danijela Kuhajda; Kosmas Tsakiridis; Andreas Mpakas; Konstantinos Zarogoulidis; Ioannis Kioumis; Sofia Lampaki; Paul Zarogoulidis; Milana Komarcevic
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

5.  Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin.

Authors:  Débora Yumi Ferreira Kamikava; Nelson Wolosker; Marcelo Fiorelli Alexandrino da Silva; José Ribas Milanez de Campos; Pedro Puech-Leão
Journal:  Clinics (Sao Paulo)       Date:  2021-06-28       Impact factor: 2.365

6.  The quality of life and satisfaction rate of patients with upper limb hyperhidrosis before and after bilateral endoscopic thoracic sympathectomy.

Authors:  Waseem M Hajjar; Sami A Al-Nassar; Heba M Al-Sharif; Dana M Al-Olayet; Wejdan S Al-Otiebi; Alanoud A Al-Huqayl; Adnan W Hajjar
Journal:  Saudi J Anaesth       Date:  2019 Jan-Mar

7.  Objective evaluation of plantar hyperhidrosis after sympathectomy.

Authors:  Nelson Wolosker; Augusto Ishy; Guilherme Yazbek; Jose Ribas Milanez de Campos; Paulo Kauffman; Pedro Puech-Leão; Fabio Biscegli Jatene
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.